Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Oxford Investment Consultants (OIC) was established in 2015 by George Robinson and Ross Hyett. The firm is headquartered in Oxford, UK, and specializes in early-stage investments in technology and biotech sectors. OIC primarily targets companies that are spinouts from Oxford University and other prestigious UK research institutions, leveraging the region's rich academic resources.
Since its inception, OIC has built a portfolio that reflects its commitment to addressing significant global challenges through innovation. The firm has grown its team to include several partners and associates, enhancing its ability to identify and support promising startups. OIC's focus on transformative companies positions it as a key player in the UK venture capital landscape.
OIC invests in companies at various stages, from Seed through to Series C funding rounds. The firm emphasizes transformative companies that tackle significant global challenges, particularly in biotechnology, healthcare, and technology. Their investment strategy is designed to support early-stage ventures that demonstrate potential for substantial impact and growth.
Geographically, OIC concentrates its efforts within the United Kingdom, particularly favoring startups that emerge from leading research institutions. The firm seeks founders who are not only innovative but also committed to addressing pressing issues in their respective fields. OIC's deal structure typically involves equity investments, and they are open to co-investment opportunities with other venture capital firms.
OIC's portfolio includes several notable companies that exemplify its investment focus:
These companies reflect OIC's commitment to investing in transformative solutions within the biotech and healthcare sectors.
George Robinson: Founding Partner with extensive experience in venture capital and a background in technology investments.
Ross Hyett: Founding Partner who has a strong track record in supporting early-stage biotech companies.
Christopher Hall: Partner with expertise in healthcare investments and a focus on transformative technologies.
James Mallinson: Partner known for his work in scaling technology startups.
Tania Wilson: Principal and CFO, responsible for financial strategy and operations.
William Middleton: Principal with a focus on identifying high-potential investment opportunities.
Alexander Chamberlain: Senior Associate with experience in biotech investments.
Hector Edwards: Associate who supports deal sourcing and due diligence processes.
Founders should pitch OIC via email at applications@oxfordinvestmentconsultants.com. It is important to include a comprehensive deck that outlines the business model, market opportunity, and team qualifications. Response times may vary, so patience is advised after submission.
In recent months, Oxford Investment Consultants has continued to expand its portfolio, focusing on transformative biotech and technology companies. Notable investments include ongoing support for companies like Biofidelity and OrganOx, which are making strides in their respective fields.
OIC remains active in the UK venture capital scene, participating in various funding rounds and collaborating with other investors to enhance opportunities for their portfolio companies.
What investment criteria does OIC look for?
OIC focuses on early-stage technology and biotech companies, particularly those that are spinouts from leading UK research institutions. They seek transformative companies that address significant global challenges.
How can I apply or pitch to OIC?
Founders can pitch their ideas by sending an email to applications@oxfordinvestmentconsultants.com. It is advisable to include a detailed business plan and any relevant data that supports the startup's potential.
What makes OIC different from other investors?
OIC's unique focus on spinouts from Oxford University and its commitment to transformative biotech and technology solutions set it apart. The firm leverages its connections within the UK research ecosystem to identify promising startups.
What is OIC's geographic scope?
OIC primarily invests in companies based in the United Kingdom, particularly those emerging from leading research institutions.
What is OIC's post-investment involvement like?
OIC typically engages with portfolio companies through board involvement and operational support, helping them navigate growth challenges and scale effectively.
What are the typical check sizes for OIC?
While specific check sizes are not disclosed, OIC invests across Seed to Series C funding rounds, indicating a range that accommodates early-stage to more developed companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.